Market Overview
Size, access gaps, and clinical demand
- Brevintel analysis values the telepharmacy market at USD 12.8 billion in 2025 ($12.8B), rising from USD 14 billion in 2026 to USD 36.9 billion by 2035 ($36.9B) at an 11.4% CAGR.
- The market encompasses remote prescription verification, dispensing support, patient counseling, medication-order review, and drug therapy monitoring delivered by licensed pharmacists through telecommunications.
- Cardinal Health led with over 17% market share in 2025; Cardinal Health, PipelineRx, CPS Solutions, CarepathRx, and Omnicell collectively held 60%.
- Demand is increasingly tied to gaps in local pharmacy access rather than convenience alone, as U.S. pharmacy closures have accelerated in communities with fewer prescription alternatives.
- Evidence from state telepharmacy policies shows that telepharmacy openings can reduce pharmacy-desert designations and improve proximity to pharmaceutical services in underserved locations.
- Noncommunicable diseases accounted for at least 43 million deaths globally in 2021, and cardiovascular disease prevalence rose from 311 million cases in 1990 to 626 million in 2023.
- Medication reconciliation, adherence support, interaction review, and longitudinal therapy monitoring become more consequential as patients manage multiple medicines over long periods.
- Telepharmacy platforms can therefore compete for budgets that would otherwise be allocated to staffing coverage, medication-safety programs, and care-transition management.
Policy, interoperability, and operating model
- Germany's Digital Act established mandatory e-prescriptions for statutory health insurance patients and expanded the role of video consultations, while Brazil has formalized telepharmacy practice and permanent controlled-medication home delivery.
- These measures do not eliminate pharmacist licensing, supervision, controlled-substance, or data-protection obligations; they make remote workflows more commercially feasible where prescribing, identity, payment, and patient-record systems can interoperate.
- Brevintel analysis estimates that the market's 11.4% growth rate through 2035 reflects a shift from isolated remote-dispensing pilots to operating models designed around persistent pharmacist scarcity and uneven pharmacy-site economics.
- The decisive issue is not whether a video connection is available; it is whether a provider can perform safe order review, counseling, escalation, and documentation across dispersed locations while maintaining local regulatory compliance.
- North America's 45.1% share reflects the relative maturity of reimbursement, pharmacy regulation, and clinical-system integration.
- The fastest expansion is expected in Asia Pacific, where the 11.8% CAGR is supported by large digital-health systems and substantial geographic variation in access.
- Providers entering those markets will need to localize operating models around national prescription rules, rural connectivity, and patient-support capacity rather than replicate a U.S. hub-and-spoke design.
- Surescripts reported nearly 24 billion exchanges of clinical and benefit information across its network in 2023, including 2.97 billion medication histories, reducing the information fragmentation that otherwise limits remote order review and counseling.
Market Dynamics
Coverage, chronic disease, and regulation
- Telepharmacy has gained relevance as physical pharmacy networks contract and hospitals struggle to maintain pharmacist coverage across all shifts.
- A study of state telepharmacy policies found that telepharmacies were more likely than traditional pharmacies to open in medically underserved areas or populations, and locations where telepharmacies became the nearest pharmacy were substantially more likely to lose their pharmacy-desert designation.
- Hospital demand is reinforced by the need for prospective medication-order review outside standard staffing hours.
- Cardinal Health states that its remote pharmacy service supports more than 450 inpatient pharmacies and reports an average order turnaround time of less than 20 minutes.
- Chronic disease creates a larger addressable need for recurring pharmacist intervention than one-time prescription fulfillment, as global cardiovascular disease prevalence more than doubled between 1990 and 2023.
- A systematic review of reviews reported that telehealth interventions in pharmacy practice can improve clinical and medication-use outcomes, including medication adherence in several reviewed studies.
- NABP has continued work on model standards involving shared pharmacy services, automated systems, remote dispensing sites, and telepharmacy.
- In Europe, Germany's e-prescription and digital-health reforms provide infrastructure for remote pharmaceutical workflows, whereas legal treatment of online prescription dispensing remains variable across EU member states.
Digital exclusion and security thresholds
- A 2025 study of 443 chronic disease patients found low current use and willingness to use telepharmacy; lower willingness was significantly associated with age of at least 50 years, inability to use the internet, and low daily smartphone use.
- Rural elderly patients interviewed in Japan identified telepharmacy's value in overcoming geographic barriers, while also describing low digital literacy and the absence of established pharmacist relationships as adoption barriers.
- Brevintel analysis indicates that services revenue of USD 4.9 billion in 2025 can grow sustainably only if providers build assisted adoption and pharmacist outreach into the operating model, rather than treating engagement as a consumer self-service task.
- Healthcare organizations reported continued cyberattack pressure in 2024, with the American Hospital Association identifying 386 attacks during the first three quarters of the year.
- A disruption can delay prescription verification and counseling, creating a direct service-continuity risk rather than merely an IT inconvenience.
- Hospital and health-system buyers require vendor controls for authentication, role-based access, auditability, incident response, and business-associate responsibilities.
- Cybersecurity is a qualification threshold: health-system buyers can defer, restrict, or redesign a deployment when the platform cannot satisfy security and continuity requirements.
- Smaller providers may prefer cloud deployment because it reduces local infrastructure demands, but outsourcing infrastructure does not transfer clinical accountability.
Segmentation Analysis
Software and services
- Software is the dominant market category and is expected to expand at an 11.6% CAGR.
- Cloud- and web-based products account for 62.8% of software demand, compared with 37.2% for on-premises deployments.
- Cloud architectures are particularly suited to multi-site networks because a central pharmacist team can access consistent workflows, reporting, and remote-verification tools across multiple locations.
- On-premises systems remain relevant for organizations with complex hospital information-system integrations, internal data-governance requirements, or specialized sterile-compounding workflows.
- Omnicell's IVX Station combines gravimetric verification, image recognition, barcode scanning, and hospital-information-system integration for IV workflow checking.
- Services generated USD 4.9 billion in 2025 and are projected to grow at an 11.1% CAGR.
- Remote dispensing accounts for 35.76% of services revenue, teleconsultation and patient counseling represent 27.32%, remote order-entry review represented 15.31%, drug therapy monitoring accounted for 12.09%, and the remaining 9.52% includes IV admixture verification, store-and-forward consultation, medication reconciliation, and specialty support.
- Brevintel analysis suggests the segment mix rewards providers that match their commercial model to the clinical intensity of the workflow: remote dispensing has the largest services share at 35.76%, but expansion is constrained by physical equipment, local permissions, and operational support.
End use
- Hospital pharmacies held 49.1% of market revenue in 2025, reflecting the need to sustain clinical review and pharmacy coverage across nights, weekends, and smaller facilities.
- CPS TELEpharmacy reports 24/7 hospital support for order entry, verification, medication reconciliation, and clinical advisory services.
- A 2023 case study reported USD 3.074 million in savings over nine months for a transitions-of-care program at a southeastern U.S. health system.
- Retail pharmacies are expected to grow at an 11.7% CAGR, as store closures and the cost of opening a full-service pharmacy create an opening for kiosks and hub-and-spoke models.
- MultiCare Health System's deployment of telepharmacy-enabled kiosks in Spokane illustrates a model in which pharmacists at existing 24/7 locations provide drug-utilization review and consultation for remote access points.
- Other end users, including long-term care centers, rural health centers, and pharmaceutical companies, are projected to grow at an 11.1% CAGR.
- Long-term care facilities require regular medication-review support for complex regimens, rural health centers prioritize access and coverage, and pharmaceutical companies may use telepharmacy channels for adherence, safety, or specialty-therapy services.
- Hospitals will continue to preserve specialized, deeply integrated deployments where medication safety and compounding workflows justify them, while retail operators have a stronger incentive to prioritize repeatable hub-and-spoke formats.
Regional Outlook
North America and Europe
- North America accounted for 45.1% of the global market in 2025.
- The U.S. market reached USD 5.4 billion, compared with USD 4.9 billion in 2024, and is expected to grow at an 11.1% CAGR.
- Its leadership reflects pharmacy-access gaps, relatively developed electronic prescribing and medication-history infrastructure, and a vendor base with established hospital and retail pharmacy relationships.
- State-level policy remains an important operational variable because telepharmacy authorization, staffing requirements, controlled-substance procedures, and remote-site standards can differ by jurisdiction.
- NABP's model-policy work and the growing number of state telepharmacy frameworks support market normalization, but suppliers still need jurisdiction-specific compliance capabilities.
- Europe represented approximately 31.3% of the global market in 2025, equivalent to USD 4.0 billion.
- Germany is a principal regional catalyst because mandatory e-prescriptions and digital-health reforms establish the prescription and data infrastructure that remote pharmaceutical workflows require.
- The European Association of E-Pharmacies has called for a framework that addresses telepharmacy through cross-border healthcare and European health-data initiatives, citing workforce pressures and the cost of medication non-adherence.
Asia Pacific, Latin America, and Middle East & Africa
- Asia Pacific accounted for approximately 18.1% of global revenue in 2025 and is forecast to grow at an 11.8% CAGR.
- India's digital-health infrastructure provides a broad foundation for pharmacy-integrated remote care: eSanjeevani had delivered more than 324 million consultations by July 2025, while the Ayushman Bharat Digital Mission had enabled 720 million digital health IDs.
- One western China internet-hospital outpatient pharmacy processed 373,936 online prescriptions between 2020 and 2023 and delivered medicines across 22 provinces, five autonomous regions, and four municipalities.
- Japan's permanent authorization of remote medication counseling and local pilots using post-office infrastructure show a pathway in which remote pharmacy access can be incorporated into existing rural-service networks.
- Latin America represented approximately 3.4% of global market revenue in 2025; Brazil provides the region's clearest regulatory base through its telepharmacy rules, national telehealth legislation, and permanent authorization for home delivery of controlled medications.
- Middle East and Africa accounted for approximately 2.0% of global revenue in 2025; Saudi Arabia is a focal market because digital-health investment under Vision 2030 is paired with a recognized rural-access rationale.
- In a 2023 survey, 77.72% of pharmacists agreed that telepharmacy can improve pharmaceutical access in rural areas, and more than 72% indicated willingness to extend services to underserved areas without additional compensation.
- Right ePharmacy operates dispensing units linked to remote pharmacists and reports support in 11 official languages across South Africa and Zambia; its Free State program reported a reduction of more than 50% in clinic congestion.
Competitive Landscape
Structure and positioning
- The market is moderately concentrated, with the top five companies collectively accounting for approximately 60% of revenue.
- Competition is organized around clinical service depth, workflow and automation technology, and the ability to operate across multiple sites while satisfying local pharmacy regulation.
- Cardinal Health combines remote pharmacy coverage with hospital and retail pharmacy relationships, stating a network of more than 450 inpatient pharmacies and more than 700 retail locations.
- PipelineRx, a CarepathRx company, focuses on cloud-based clinical telepharmacy and medication-management workflows for health systems.
- CarepathRx supports health-system pharmacy operations and has expanded its strategic relationship with Evernorth, reinforcing specialty-pharmacy and payer-adjacent capabilities.
- CPS TELEpharmacy competes through centralized 24/7 hospital-service delivery, particularly in remote order review, medication reconciliation, and clinical advisory support.
- Omnicell differentiates through automation-integrated medication management, including IV compounding and remote expert oversight; it reported FY2024 revenue of USD 1.112 billion.
- AZOVA's 2023 UTI Telehealth Bundle combined testing and telehealth access in Walmart stores and online, while ScriptPro's platform combines robotic dispensing, verification, and remote counseling workflows.
Hospital service platforms
- Cardinal Health
- PipelineRx
- CPS Solutions
- CarepathRx
Automation and specialty networks
- Omnicell
- AZOVA
- ScriptPro Telepharmacy
- OSP Telepharmacy Solutions
- OutcomesMTM
- Zane Networks
- Right ePharmacy
- Indispensable Health TelepharmRx
- Infinipharm Telepharmacy